Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 9, keine Gesamtzahl für „randomised“
Suchtreffer
Begriffe & Kennungen
Revolade · 4.8 · ENABLE 1 (TPL103922 n=716, 715 treated with eltrombopag) and ENABLE 2 (TPL108390 n=805) were randomised, doubl
Eintrag öffnenRevolade · 4.8 · ENABLE 1 (TPL103922 n=716, 715 treated with eltrombopag) and ENABLE 2 (TPL108390 n=805) were randomised, doubl
Eintrag öffnenReyataz · 4.8 · a statistical calculation based on the total number of patients exposed to REYATAZ in randomised controlled an
Eintrag öffnenReyataz · 4.8 · a statistical calculation based on the total number of patients exposed to REYATAZ in randomised controlled an
Eintrag öffnenRixathon · 4.8 · A multicentre, open-label randomised study of Lymphome Malin B chemotherapy (LMB) with or without rituximab wa
Eintrag öffnenRixathon · 4.8 · In PV Study 2, a randomised, double-blind, double-dummy, active-comparator, multicentre study evaluating the e
Eintrag öffnenRiximyo · 4.8 · A multicentre, open-label randomised study of Lymphome Malin B chemotherapy (LMB) with or without rituximab wa
Eintrag öffnenRiximyo · 4.8 · In PV Study 2, a randomised, double-blind, double-dummy, active-comparator, multicentre study evaluating the e
Eintrag öffnenRoActemra · 4.8 · Patients with COVID-19 The safety evaluation of this medicinal product in COVID-19 was based on 3 randomised,
Eintrag öffnenRuxience · 4.8 · A multicentre, open-label randomised study of Lymphome Malin B chemotherapy (LMB) with or without rituximab wa
Eintrag öffnenRuxience · 4.8 · In PV Study 2, a randomised, double-blind, double-dummy, active-comparator, multicentre study evaluating the e
Eintrag öffnenRuxolitinib Viatris · 4.8 · Elevated lipase In the randomised period of the RESPONSE study, the worsening of lipase values was higher in t
Eintrag öffnenRuxolitinib Viatris · 4.8 · In the randomised period of the phase 3 studies in PV patients, neutropenia was reported in 1.6% of patients e
Eintrag öffnenRuxolitinib Viatris · 4.8 · In the randomised period of the phase 3 studies in PV patients, one (0.5%) CTCAE grade 3 and no grade 4 urinar
Eintrag öffnenRuxolitinib Viatris · 4.8 · In the randomised period of the pivotal studies, anaemia was less frequent in PV patients than in MF patients
Eintrag öffnenRuxolitinib Viatris · 4.8 · In the randomised period of the pivotal studies, the rate of patients experiencing thrombocytopenia was lower
Eintrag öffnenRuxolitinib Viatris · 4.8 · In the randomised period of the pivotal study in PV patients, the mean systolic blood pressure increased by 0.
Eintrag öffnenRuxolitinib Viatris · 4.8 · In the randomised, placebo-controlled study COMFORT-I 60.6% of ruxolitinib-treated MF patients and 37.7% of pl
Eintrag öffnenSelincro · 4.8 · The frequencies of the adverse reactions in Table 1 were calculated based on three randomised, double-blind, p
Eintrag öffnenSilapo · 4.8 · 16 Adult patients with low- or intermediate-1-risk MDS In the randomised, double-blind, placebo-controlled, mu
Eintrag öffnen